Safety and clinical response of tumor necrosis factor-α inhibitor adalimumab in the treatment of severe acne: A real-world study

Journal of the American Academy of Dermatology 2026

View at publisher

Authors: Xiaoli Li, Xin Liu, Yufei Wu, Jialin Lian, Danyang Yang, Jiayi Han, Ruilian Li, Ruilian Li, Xiaoli Li

DOI: 10.1016/j.jaad.2026.01.073

Cited by: 0

References: 3

Fields of Study & Subjects

Acne and Rosacea Treatments and Effects Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis

References 3